Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. USRDS. United States Renal Data System.

× No keyword cloud information.

10 in total

Review 1. A practical review of the use of stents for the maintenance of hemodialysis access.

Authors: Michael Ginsburg; Jonathan M Lorenz; Sean P Zivin; Steven Zangan; Don Martinez
Journal: Semin Intervent Radiol Date: 2015-06 Impact factor: 1.513

2. Risk factors associated with patency loss of hemodialysis vascular access within 6 months.

Authors: Mauricio Monroy-Cuadros; Serdar Yilmaz; Anastasio Salazar-Bañuelos; Christopher Doig
Journal: Clin J Am Soc Nephrol Date: 2010-06-24 Impact factor: 8.237

3. Reconciling decision models with the real world. An application to anaemia of renal failure.

Authors: Y C Shih; T L Kauf
Journal: Pharmacoeconomics Date: 1999-05 Impact factor: 4.981

4. Synthetic vascular hemodialysis access versus native arteriovenous fistula: a cost-utility analysis.

Authors: Sylvia E Rosas; Harold I Feldman
Journal: Ann Surg Date: 2012-01 Impact factor: 12.969

5. Economics of the antithymocyte globulins Thymoglobulin and Atgam in the treatment of acute renal transplant rejection.

Authors: M A Schnitzler; R S Woodward; J A Lowell; L Amir; T J Schroeder; G G Singer; D C Brennan
Journal: Pharmacoeconomics Date: 2000-03 Impact factor: 4.981

6. Pharmacomechanical Thrombolysis of Dialysis Access Grafts Using the MTI Castañeda Over-the-Wire Brush Catheter and Reteplase.

Authors: Alexjandro Mendez-Castillo; Syed Hassain; Flavio Castañeda
Journal: Semin Intervent Radiol Date: 2004-06 Impact factor: 1.513

The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. USRDS. United States Renal Data System.

Review 1. A practical review of the use of stents for the maintenance of hemodialysis access.

2. Risk factors associated with patency loss of hemodialysis vascular access within 6 months.

3. Reconciling decision models with the real world. An application to anaemia of renal failure.

4. Synthetic vascular hemodialysis access versus native arteriovenous fistula: a cost-utility analysis.

5. Economics of the antithymocyte globulins Thymoglobulin and Atgam in the treatment of acute renal transplant rejection.

6. Pharmacomechanical Thrombolysis of Dialysis Access Grafts Using the MTI Castañeda Over-the-Wire Brush Catheter and Reteplase.

Review 7. Thrombosis in the uremic milieu--emerging role of "thrombolome".

8. Increased venous proinflammatory gene expression and intimal hyperplasia in an aorto-caval fistula model in the rat.

9. Relationship between Vessel Diameter and Time to Maturation of Arteriovenous Fistula for Hemodialysis Access.

10. Effect of insurance on prescription drug use by ESRD beneficiaries.